CenExel

Are you at ACNP 2024 in Phoenix? Be sure to connect with CenExel leaders Larry Ereshefsky PharmD, FCCP, BCPP, David Walling, and Diana Shuster, PhD! Would you like to learn more about how CenExel can support your clinical research? Visit www.cenexel.com for more information! #CenExel #ACNP2024 #clinicalresearch

We are thrilled to celebrate CenExel HRI for being named Best Medical Research Site by Metro Philly for the fourth year in a row! This incredible achievement is a testament to the team's unwavering dedication, expertise, and tireless efforts in advancing clinical research. The team at CenExel HRI's hard work and commitment to delivering excellence makes a real difference in the lives of patients and the progress of medical science. We couldn’t be more proud of the impact they continue to make in the New Jersey and Pennsylvania communities and beyond. Thank you for setting the standard in research excellence—here’s to continued success and many more accolades ahead! 🎉👏 #ExcellenceInResearch #CenExelHRI #MetroPhillyBest

At CenExel, we collaborate with central IRBs, such as Advarra, to fast-track agreements and expedite your study start-up. This partnership helps you meet critical deadlines while ensuring that quality remains uncompromised. Our commitment to strong relationships not only accelerates the initiation of your trials but also supports a smooth process from start to finish. Choose CenExel to enhance your trial efficiency and achieve your research goals without delays. Learn more by visiting www.cenexel.com! #ClinicalTrials #CenExel #IRBPartnerships #Efficiency

CNS Summit starts today!! Are you in Boston? Come connect with #CenExel executives Ryan Brooks, Larry Ereshefsky PharmD, FCCP, BCPP, Diana Shuster, PhD and David Walling, PhD as they discuss innovation and breakthroughs in clinical research. Learn about CenExel’s commitment to advancing CNS trials, quality data, and patient care by visiting www.cenexel.com, and meet with us by emailing [email protected]. Let’s shape the future of CNS together! #CNSSummit #ClinicalResearch #CNS

Congratulations to Craig Shapiro, DO, Principal Investigator at CenExel RCA on his article published in Human Vaccines & Immunotherapeutics, titled "Safety and immunogenicity of a modified mRNA-lipid nanoparticle vaccine candidate against COVID-19: Results from a phase 1, dose-escalation study." To read the article, visit --> https://lnkd.in/dTxPrUDr Congratulations, Dr. Shapiro! #CenExel #Phase1Trials #Covid19ClinicalTrials #VaccineClinicalTrials

On Monday, November 11 from 5-7pm ET, three incredible CenExel leaders will be presenting posters at CNS Summit! Join Judith Montero, PsyD, Cassie Berger Blanchard, Ph.D. and Dr. Thomas Shiovitz, MD in Boston as they showcase posters 15, 16 and 24. Want to connect with the presenters? Reach out to [email protected]! Looking forward to seeing everyone! #CenExel #PosterPresentations #CNSSummit2024

The CenExel Business Development team will be on board to meet with you in Boston at CNS Summit 2024! If you'd like to connect with Jeanette Caruso or Lauren White, send us an email at [email protected]. We're looking forward to seeing you! #CenExel #CNSSummit2024 #BusinessDevelopment

CenExel is excited to share that several of our esteemed Principal Investigators will be in Boston for CNS Summit! If you'd like to meet with Cassie Berger Blanchard, Ph.D., Elyssa Barron, MD, Elan Cohen, PhD, Edwin Gomez, MD, or Lara Shirikjian, DO, send us an email at [email protected]. Looking forward to seeing you in Boston! #CenExel #PrincipalInvestigators #CNSSummit2024

Congratulations to Amina Haggag, MD, Principal Investigator at CenExel ACT on her article published in Diabetes, Obesity and Metabolism, titled "Evaluation of an oral small-molecule glucagon-like peptide-1 receptor agonist, lotiglipron, for type 2 diabetes and obesity: A dose-ranging, phase 2, randomized, placebo-controlled study." To read the article, visit --> https://lnkd.in/dccMygab Congratulations, Dr. Haggag! #CenExel #Phase2Trials #DiabetesClinicalTrials #ObesityClinicalTrials

CenExel makes clinical trial management easier with one contract and harmonized quality systems across all sites. This streamlined process ensures consistency, reduces complexity, and improves efficiency, helping you stay focused on advancing your trial. By simplifying coordination and maintaining high standards across the board, we provide the support you need for smooth and successful trial execution. Partnering with CenExel means reliable, efficient results. Want to learn more? Visit www.cenexel.com! #ClinicalTrials #CenExel #Efficiency